APPLICATION
ANDA090359
TYPE
ANDA
ORIGINAL APPROVAL
2013-02-05
LATEST ACTION
2019-10-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
MEFENAMIC ACIDDiscontinued
MEFENAMIC ACID 250MG · CAPSULE · ORAL
Approval history
2019-10-29Labeling · Supplement 3 · standardAP
2014-12-30Manufacturing (CMC) · Supplement 2AP
2013-07-31Labeling · Supplement 1 · standardAP
2013-02-05OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.